Friday, March 28, 2025
Registration
Welcome Remarks
Carl Salzman, MD; Matcheri Keshavan, MD
Update on the Neurobiology for the Practicing Clinician: Understanding Brain Function and its Clinical Relevance
Matcheri Keshavan, MD
Treatment-Resistant Depression: Update on New Antidepressants, Polypharmacy, Augmentation Strategies, Ketamine, Psychedelics, and ECTÂ
Alan Schatzberg, MD
Treatment of Bipolar Disorders; Neurobiology and Clinical Directions; Revival of Lithium
Roscoe Brady, MD
Coffee Break
Update: The Psychopharmacology of the Reproductive Life Cycle: Premenstrual, Pregnancy, Lactation, and Menopause
Kristina Deligiannidis, MD
Psychopharmacologic Approaches in Childhood Affective Disorders
Melissa Delbello, MD, MS
Panel Discussion #1
Roscoe Brady, MD; Matcheri Keshavan, MD; Alan Schatzberg, MD; Kristina Deligiannidis, MD; Melissa Delbello, MD, MS
LunchÂ
Clinical Relevance of Brain Circuity for Psychiatric Treatment
Roscoe Brady, MD
Psychopharmacology in Geriatrics and Neuropsychiatry
Alejandro (Danny) Mendoza, MD
Coffee Break
Therapeutic Approaches to the Difficult Patient
Stephen Stahl, MD, PhD, DSc (Hon)
Panel Discussion #2
Roscoe Brady, MD; Alejandro (Danny) Mendoza, MD; Stephen Stahl, MD, PhD, DSc (Hon)
Saturday, March 29, 2025
Treatment for Schizophrenia: Prodrome First Episode, Relapse and New Treatment Possibilities
Matcheri Keshavan, MD
Neurobiology and Treatment of Sleep in Psychiatric Disorders
John Winkelman, MD;Â Tony Cunningham, PhD
Coffee Break
Update: Digital Phenotyping in Psychiatry and Psychopharmacology; Role of AI?
John Torous, MD, MBI
Clinical Use for Psychedelics? Use for PTSD?
Ryan Henner, MD
Panel Discussion #1
Carl Salzman, MD; John Torous, MD, MBI; John Winkelman, MD; Ryan Henner, MD;Â Tony Cunningham, PhD
LunchÂ
Update: Effective Treatment of Substance Use Disorders
Kevin Hill, MD
Treatment of Anxiety Spectrum Disorders, and PTSD, New Benzodiazepine Data
Carl Salzman, MD
Coffee Break
Psychopharmacology of Trauma Related Disorders
Charles Nemeroff, MD, PhD
Panel Discussion #2
Carl Salzman, MD; Charles Nemeroff, MD, PhD; Matcheri Keshavan, MD; Kevin Hill, MD
Wrap-Up, Last Questions
Sarah Johnson –
“An exceptional master class! The depth of knowledge shared about psychopharmacology was impressive.”
Michael Lee –
“The faculty were outstanding. Their expertise made complex topics easy to understand and apply.”
Emily Davis –
“I loved the interactive discussions. The case studies offered practical insights that I can use in my practice.”
David Martinez –
“A must-attend for anyone in mental health! The latest research presented was enlightening.”
Jessica Brown –
“The course covered a wide range of topics, from medication management to emerging therapies. Highly recommend!”
Robert Wilson –
“I was impressed by the quality of the presentations. Every session was engaging and informative.”
Chris Garcia –
“The curriculum was well-structured and easy to follow. I felt fully engaged throughout the course.”
Laura Harris –
“The updates on treatment protocols were invaluable. I feel more confident in my prescribing practices now.”
James Robinson –
“This master class provided practical tools that I can implement immediately in my work.”
Olivia Clark –
“The focus on evidence-based practices was particularly enlightening. I learned so much!”
Timothy Young –
“The course was well-paced, and the information was relevant to my practice. Highly recommend!”
Megan Hall –
“Incredible experience! The discussions on neurobiology and pharmacology were particularly useful.”
Joshua King –
“I left feeling inspired and better prepared for my practice. Thank you to the faculty!”
Benjamin Lopez –
“The case discussions were interactive and insightful. I learned a lot from my peers.”
Samantha Hill –
“This master class was a game-changer for my approach to psychopharmacology. I highly recommend it!”